Showing 1 - 10 of 51,252
We analyze the doping behavior of heterogeneous athletes in an environment of private information. In a n-player strategic game, modeled as an all-pay auction, each athlete has private information about his actual physical ability and choses the amount of performance-enhancing drugs. The use of...
Persistent link: https://www.econbiz.de/10009772194
Persistent link: https://www.econbiz.de/10011326793
Persistent link: https://www.econbiz.de/10003844289
We study the spillover effects of prescription drug monitoring programs (PDMPs) on crime, and in the process inform how policies that restrict access to Rx opioids per se within the healthcare system would impact broader non-health domains. In response to the substantial increase in opioid use...
Persistent link: https://www.econbiz.de/10012911712
Persistent link: https://www.econbiz.de/10012819813
For almost two decades, Virginia has used risk assessment to justify “alternative” nonprison sentences for eligible drug and property offenders. In Study 1, we examined how frequently alternative sentences actually were imposed. We found that alternative sentences were given to only 42% of...
Persistent link: https://www.econbiz.de/10012864768
Persistent link: https://www.econbiz.de/10012872409
Persistent link: https://www.econbiz.de/10013206259
There have been more than 500,000 opioid overdose deaths since 2000. To analyze the opioid epidemic, we construct a model where individuals, with and without pain, choose whether to misuse opioids knowing the probabilities of addiction and dying. These odds are functions of opioid use. Markov...
Persistent link: https://www.econbiz.de/10012887735
Canadian household prescription drug expenditures are studied using different years of the Statistics Canada Family Expenditure Survey. Master files are used, expanding the number of available years and permitting provincial rather than regional identifiers. Nonparametric Engel curves are...
Persistent link: https://www.econbiz.de/10013320093